Medazol (Metronidazole)

Metronidazole penetrates susceptible microbial cells and is reduced to reactive nitro radicals. These radicals damage microbial DNA by causing strand breaks and disrupting nucleic acid synthesis, which leads to cell death. This mechanism is effective against anaerobic bacteria and certain protozoa, making it useful for the infections listed under its indications.

The dosage of Medazol is individualized by the prescribing healthcare professional based on the specific infection, patient age, weight, renal and hepatic function, and other clinical factors. Patients should follow the prescriber’s instructions precisely and not alter the dose without medical advice.

Metronidazole is classified as a pregnancy category B drug in many regions, indicating that animal studies have not shown risk but adequate human studies are lacking. It should be used during pregnancy only if clearly needed and after consulting a healthcare provider. Metronidazole is excreted in breast milk; breastfeeding mothers should discuss risks and benefits with their clinician.

To request Medazol, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Metronidazole is a nitroimidazole that specifically targets anaerobic organisms and certain protozoa, offering a broad spectrum against these pathogens. Compared with beta‑lactam antibiotics, it provides effective coverage for anaerobes without the need for beta‑lactamase inhibitors, but it lacks activity against aerobic bacteria, so choice depends on the infection’s microbial profile.

Medazol should be stored at temperatures below 25 °C in a dry place. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children. Do not store in the bathroom or near heat sources.

Medazol is supplied as oral tablets that are taken by mouth with or without food, as directed by the prescriber. The tablets should be swallowed whole with a full glass of water. Patients should not crush or chew the tablets unless specifically instructed by a healthcare professional.

Serious adverse reactions to Metazol include seizures, peripheral neuropathy, severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, and hepatotoxicity. Patients should seek immediate medical attention if they experience neurological symptoms, severe skin reactions, or signs of liver injury while taking the medication.

Medazol is contraindicated in individuals with a known hypersensitivity to metronidazole or other nitroimidazole compounds. It should also be avoided in patients with a history of severe reactions to alcohol when combined with metronidazole, and in those for whom the prescriber determines the risks outweigh the benefits, such as certain pregnant women or patients with severe liver disease.